- Home
- RMT vs AUTL Comparison
RMT vs AUTL Comparison
Compare RMT & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMT
- AUTL
- Stock Information
- Founded
- RMT 1993
- AUTL 2014
- Country
- RMT United States
- AUTL United Kingdom
- Employees
- RMT N/A
- AUTL N/A
- Industry
- RMT Investment Managers
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RMT Finance
- AUTL Health Care
- Exchange
- RMT Nasdaq
- AUTL Nasdaq
- Market Cap
- RMT 445.0M
- AUTL 359.3M
- IPO Year
- RMT N/A
- AUTL 2018
- Fundamental
- Price
- RMT $8.93
- AUTL $2.12
- Analyst Decision
- RMT
- AUTL Strong Buy
- Analyst Count
- RMT 0
- AUTL 5
- Target Price
- RMT N/A
- AUTL $9.32
- AVG Volume (30 Days)
- RMT 111.5K
- AUTL 2.5M
- Earning Date
- RMT 01-01-0001
- AUTL 05-08-2025
- Dividend Yield
- RMT 7.37%
- AUTL N/A
- EPS Growth
- RMT N/A
- AUTL N/A
- EPS
- RMT 1.49
- AUTL N/A
- Revenue
- RMT N/A
- AUTL $9,011,000.00
- Revenue This Year
- RMT N/A
- AUTL $329.53
- Revenue Next Year
- RMT N/A
- AUTL $191.73
- P/E Ratio
- RMT $6.18
- AUTL N/A
- Revenue Growth
- RMT N/A
- AUTL N/A
- 52 Week Low
- RMT $7.67
- AUTL $1.11
- 52 Week High
- RMT $9.51
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- RMT 64.23
- AUTL 78.49
- Support Level
- RMT $8.66
- AUTL $1.19
- Resistance Level
- RMT $8.89
- AUTL $1.79
- Average True Range (ATR)
- RMT 0.14
- AUTL 0.12
- MACD
- RMT 0.00
- AUTL 0.08
- Stochastic Oscillator
- RMT 89.52
- AUTL 97.54
About RMT Royce Micro-Cap Trust Inc.
Royce Micro-Cap Trust Inc is a diversified closed-end investment company. The company is engaged in investing in micro-cap securities. It invests in the consumer discretionary sector including auto components, automobiles, diversified consumer services, hotels, restaurants and leisure, household durables, internet and catalog retail, leisure products, media, multiline retail, textiles, apparels, and luxury goods, Consumer staples sector including beverages, food, and staples retailing, food products, and personal products, Energy sector including energy equipment and services, and oil, gas, and consumable fuels. The company also invests in other sectors including healthcare, financials, industrials, IT, telecommunications, and materials.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.